Inversine

   
Google
 
Web NewDrugInformation.com

Inversine


Drug - Inversine
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Mecamylamine Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 2.5MG
The potency of the active ingredient(s), Mecamylamine Hydrochloride. May repeat for multiple part products.

Applicant - TARGACEPT
The firm name holding legal responsibility for Inversine. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 010251
The FDA assigned number to Inversine. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Inversine. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Inversine was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Inversine. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Inversine is in. Format is RX, OTC, DISCN.

Applicant Full Name - Targacept Inc
The full name of the firm holding legal responsibility for the new application of Inversine.

Inversine